Hydroxyzine Pamoate
- Product NDC
- 42291-406
- 11-digit product format
- 422910406
- Labeler code
- 42291
- Product ID
- 42291-406_cc96d222-a1ab-64f8-e053-2a95a90a3805
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Pamoate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA040156
- Marketing category
- ANDA
- Marketing start
- 2018-04-12
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-406-50 | 42291040650 | 500 CAPSULE in 1 BOTTLE, PLASTIC (42291-406-50) | 500 capsule | 2018-04-12 | 0000-00-00 | No | No | Current |
| 42291-406-90 | 42291040690 | 90 CAPSULE in 1 BOTTLE, PLASTIC (42291-406-90) | 90 capsule | 2018-04-12 | 0000-00-00 | No | No | Current |